The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company’s chief executive officer Adar Poonawalla
Northeast India News, Assam News, Breaking News of Northeast | Latest News Live | EastMojo
The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company’s chief executive officer Adar Poonawalla
Disclaimer: Stories/articles published under EM Buzz (eastmojo.com/em-buzz) are provided by third parties and EastMojo.com has no direct relation with these articles.
Sign in to activate your ad-free experience.
Enter your membership email and we'll send you a secure login link.
Not a member yet? Become a Member →